Substitution treatment for opioid addicts in Germany

Harm Reduction Journal

Volumn 4, Issue , 2007, Pages

  Michels, Ingo Ilja ^a   Stöver, Heino ^b   Gerlach, Ralf ^c  

^a Federal Ministry of Health   (Germany)

^b UNIVERSITY OF BREMEN   (Germany)

^c Institute for the Advancement of Qualitative Drug Research (INDRO)   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; COCAINE; CODEINE; DIAMORPHINE; DIHYDROCODEINE; LEVACETYLMETHADOL; LEVOMETHADONE; METHADONE;

ARTICLE; COUNSELING; DRUG USE; EMPLOYMENT; GENERAL PRACTITIONER; GERMANY; HARM REDUCTION; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH SERVICES RESEARCH; HEART DISEASE; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INTEGRATION; LOW DRUG DOSE; MENTAL HEALTH; METHADONE TREATMENT; MORBIDITY; MORTALITY; OPIATE ADDICTION; PATIENT CARE; PRACTICE GUIDELINE; PRISON; PSYCHOSOCIAL CARE; RURAL AREA; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

EID: 33847200739     PISSN: None     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/1477-7517-4-5     Document Type: Article

References (69)

1. Newman RG Is there a Role for Methadone in Germany? AIDS & Public Policy Journal 1988 3 23-29 11650099
2. Michels II Critical Analysis of the Drug Treatment Policy in Germany Aids and Drug Addiction in the European Community, Proceedings of a Seminar on AIDS and Drug Addiction in the Twelve European Communities Member States, Brussels July 1-2 European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon Reisinger M 1993 90-102
3. Verthein U Kalke J Raschke P Substitution treatment with methadone in Germany: Politics, programmes and results International Journal of Drug Policy 1998 9 71-78 10.1016/S0955-3959(97)00012-1
4. Gerlach R Drug Substitution Treatment in Germany: A Critical Overview of its History, Legislation and Current Practice Journal on Drug Issues 2002 2 503-522
5. Michels II Substitutionsbehandlungen in Deutschland - vom Tal der Tränen in die Mühen der Ebene (Substitution treatment in Germany - from the valley of tears to the hardship of the plain) Vom Tabu zur Normalität. 20 Jahre Substitution in Deutschland. Zwischenbilanz und Aufgaben für die Zukunft. Freiburg i.Br Gerlach R, Stöver H 2005 359-369
6. Krach C Ambulantes Therapieprogramm mit Methadon Niedersächsisches Ärzteblatt 1978 51 289-293 Krach C, Peschke H: Das Hannoversche Methadonprogramm. 11 Jahre danach. Unpublished manuscript. Hannover 1987
7. Newman RG Another Wall That Crumbled - Methadone Maintenance Treatment in Germany American Journal of Drug & Alcohol Abuse 1995 21 27-35
8. Ministerium für Arbeit, Gesundheit und Soziales des Landes Nordrhein-Westfalen (ed) Medikamentengestützte Rehabilitation i.v. Opiatabhängiger - Katamnese (Medication-supported rehabilitation of iv drug addicts - follow-up) Düsseldorf 1998
9. Bätzing S Zwischen Abstinenztherapie und Diamorphinvergabe - die Substitutionsbe-handlung von Drogenabhängigen in Deutschland heute und morgen Statement im Rahmen des 5. Parlamentarischen Abends der sanofi-aventis Deutschland GmbH am 20. September 2006 in Berlin (Between abstinence therapy and provision of diamorphine - substitution treatmrent of opioid dependents in Germany. Statement at the 5th Parlamentarian Evening of sanofi-aventis Germany on 20th September 2006 in Berlin)
10. Wittchen HU Apelt SM Mühlig S Die Versorgungslage der Substitutionstherapie (The provision of substitution treatment). Vom Tabu zur Normalität. 20 Jahre Substitution in Deutschland. Zwischenbilanz und Aufgaben für die Zukunft. Freiburg i.Br Gerlach R, Stöver H 2005 64-77
11. Ulmer A Die Dihydrocodein-Substitution (Substitution treatment with dihydrocodeine) Stuttgart/New York 1997
12. Poehlke T Flenker I Schlüter HJ Busch H Suchtmedizinische Versorgung. (Provision of Addiction Medicine) Berlin 2000
13. Follmann A Nolting HD Qualitätsorientiertes Management der Substitution im Alltag (Quality-oriented management of substitution treatment) Suchtmed 2004 6 127-130
14. Simon R David-Spickermann M Farke W National Report to the EMCDDA by REITOX Focal Point Germany New Developments, Trends and In-Depth Information on Selected Topics., Munich/Lisbon 2005
15. Agostini R Substitutionsbehandlungen im Rahmen stationärer Therapie (Substitution treatment in the framework of inpatient therapy). Vom Tabu zur Normalität. 20 Jahre Substitution in Deutschland. Zwischenbilanz und Aufgaben für die Zukunft. Freiburg i.Br Gerlach R, Stöver H 2005 126 133
16. Die Drogenbeauftragte der Bundesregirung Perspektiven für suchtkranke Menschen Dokumentaion der Fachtagung, Teilhabe am Arbeitsleben' am 20. und 21. Oktober 2005 (Federal Drugs Commissioner: Perspectives for addicted persons. Documentation of the Seminar on 'Taking Part in Working Life'); Berlin 2006
17. JES (Junkies Exusers Substitute Drug Users) Documents of the work of JES among intravenous drug users in Germany German AIDS Help, Berlin 1991
18. van den Brink W Haasen Ch Evidenced based treatment of opioid dependent patients Can J Psychiatry 2006 10 635-645
19. Degkwitz P Chorzelski G Krausz M 'Five Years of Methadone Prescription in Germany' Aids and Drug Addiction in the European Community, Proceedings of a Seminar on AIDS and Drug Addiction in the Twelve European Communities Member States, Brussels July 1-2 European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon Reisinger M 1993 81-89
20. Küfner H Rösner S Forschungsstand zur Substitutionsbehandlung: Ergebnisse zur Evaluation und Indikation (State of the art in research on substitution treatment). Vom Tabu zur Normalität. 20 Jahre Substitution in Deutschland. Zwischenbilanz und Aufgaben für die Zukunf. Freiburg i.Br Gerlach R, Stöver H 2005 29 63
21. Raschke P Verthein U Kalke J Substitution in Hamburg - Methadonbehandlung Opiatabhängiger von 1990 bis 1995 (Substitution in Hamburg - Methadone Treatment of Opiate Addicts from 1990 to 1995) Hamburg 1996
22. Finkbeiner T Gastpar M Der aktuelle Stand der Substitutionsbehandlung Drogenabhängiger (Current status of substitution treatment of opioid dependent drug users) Nervenheilkunde 1997 16 215-221
23. Gerlach R Germany Reviewing current practice in drug-substitution treatment in the European Union European Monitoring Centre for Drugs and Drug Addiction. Lisbon 2000 69-97
24. Haasen Ch van den Brink W Innovations in agonist maintenance treatment of opioid-dependent patients Curr Opin Psychiatry 2006 19 631-636 10.1097/01.yco.0000245759.13997.9d 17012944
25. Michels II Heroin-based treatment Journal of Drug Issues 2002 2 523-542
26. Haasen Ch Verthein U Degkwitz P Berger J Krausz M Naber D Heroin-assisted treatment for opioid dependence - a randomised, controlled clinical trial. Report to the Federal Ministry of Health Berlin 2006
27. Gerlach R Stöver H Begleitende psychosoziale Unterstützung in der Substitutionsbehandlung (additional psychosocial support in substitution treatment) Opiatabhängigkeit. Springer. Vienna Beubler E, Haltmayer H, Springer A 2 2007 225-230
28. Scherbaum N Kluwig J Specka M Krause D Merget B Finkenbeiner T Gaspar M Group psychotherpy for opiate addicts in methadone maintenance treatment - A controlled trial Eur Ad Res 2005 11 163-171 10.1159/000086397
29. Scherbaum N Nielebock A Banger M Marziniak B Contingency management in maintenance treatment of opiate addicts Lecture at the 2nd Meeting of the German Addiction Research Network, Dresden 25-26 May, 2006
30. Christie G Hil R Service Users' and Providers' Perceptions of a Methadone Maintenance Program: A Queensland Qualitative Pilot Study Queensland University of Technology, Brisbane 2000
31. Stöver H Hennebel L Casselmann J Substitution Treatment in European Prisons. A study of policies and practices of substitution treatment in prisons in 18 European countries London/Oldenburg 2004 209
32. Elsner H "Beigebrauch" von Benzodiazepinen in der Methadonbehandlung: Medizinisch korrekte Selbstmedikation gegen die Methadonassoziierten Schlafstörungen? (Collateral use of benzodiazepines during methadone treatment: Medicinally appropriate self-medication of dyssomnia associated with methadone?) Suchttherapie 2006 7 8-12
33. Gerlach R Caplehorn JRM Attitudes and beliefs of doctors prescribing methadone to addicts in the Westfalen-Lippe region of Germany Drug and Alcohol Review 1999 18 163-170 10.1080/09595239996590
34. Wittchen HU Apelt S Christl B Hageman K Gross A Klotsche J Soyka M Die Versorgungspraxis der Substitutiontherapie Opiatabhängiger (COBRA) (The provision of substitution treatment of opiate addicts). Suchtmed 2004 6 80-87
35. EMEA (European Agency for the Evaluation of Medicinal Products) EMEA Public Statement on the Recommendation to Suspend the Marketing Authorisation for ORLAAM (Levacetylmethadol) in the European Union London 19 April 2001
36. Finkbeiner T Hagen S Wolstein J Differenzierte Substitutionstherapie mit LAAM (Differentiated substitution treatment with LAAM) In Suchtmedizin - aktuell. Berlin Zerdick J 2000 165-169
37. Krausz M Verthein U Degkwitz P Haasen C Raschke P Maintenance treatment of opiate addicts in Germany with medications containing codeine - results of a follow-up study Addiction 1998 93 1161-1167 10.1046/ j.1360-0443.1998.93811614.x 9813897
38. Degkwitz P Farnbacher G Kalke J Schmidt V Verthein U Die Umstellung der Substitution von Codein auf Methadon - Kurzfassung einer Studie über die Auswirkungen neuer betäubungsmittelrechtlicher Vorschriften (Switching from Codeine to Methadone. A study on the effects of new regulations of the narcotic law) Suchtmedizin - aktuell. Berlin Zerdick J 2000 171-206
39. Hönekopp I Buprenorphin-Substitution in der Schwangerschaft: Geringeres Risiko neonataler Abstinenzsyndrome (Substitution with buprenorphine in Pregnancy: Reduced risk of neonatal withdrawal symptoms) Suchtmed 2000 2 166-167
40. Berger H Türbsch L Wambach L Buprenorphin in der Detoxifikation: Erste Erfahrungen im psychiatrischen Alltag (Buprenorphine in detox: first experiences in clinical practice) Suchtmed 2000 2 112-113
41. Brack J Behrendt K Erfahrungen mit dem Einsatz von Buprenorphin in der qualifizierten stationären Entzugsbehandlung Opiatabhängiger (Experiences with the use of buprenorphine in qualified inpatient detoxification treatment of opiate addicts) Suchtmed 2004 6 241-248
42. Sung S Conry JM Role of buprenorphine in the management of heroin addiction Ann Pharmacother 2006 40 501-505 10.1345/aph.1G276 16434562
43. Madlung E Dunkel D Haring C Substitutionsmittel und Beikonsum bei Opiatabhängigen. Eine explorative Sudie unter besonderer Berücksichtigung von retardierten Morphinen in der Substitutionsbehandlung (Substitution Treatment and Additional consumption of Legal and Illegal Drugs in Opioid Addicts - An Exploraty Study with Special Reference to Slow-released Morphine in Substitution Treatment) Suchttherapie 2006 7 18-23
44. Behrendt K Chorzelski G Meyer-Thompson HG Gibt es einen "Goldstandard" der Substitutionsbehandung Methadon/Polamidon? (Is there a, gold standard' for Maintenance Treament with Methdone/ Levomethadone?) Suchttherapie 2006 7 78-81
45. Stöver H Drug Substitution Treatment and Needle Exchange Programs in German and European Prisons Journal on Drug Issues 2002 2 573-595
46. WHO Guidelines of HIV and AIDS in Prisons. Geneva 1993
47. Keppler KH Methadonsubstitution im Gefängnis (Methadone treatment in prisons) AIDS. Landsberg Jäger H 2000 530-534
48. Stöver H Casselmann J Subtitutionsbehandlungen in europäischen Gefängnissen (Substitution Treatment in European Prisons) Suchttherapie 2006 7 66-71
49. Stöver H Casselmann J Hennebel L Substitution treatment in European prisons: A study of policies and practices in 18 European countries International Journal of Prisoner Health 2006 2 3-12 10.1080/ 17449200600743396
50. Robert Koch-Institut HIV-Infektionen und AIDS-Erkrankungen in Deutschland. Aktuelle epidemiologische Daten Epidemiologisches Bulletin. (HIV infections and AIDS in Germany) Special Issue A, April 2005
51. Robert Koch-Institut (RKI) Hepatitis C. Gesundheitsberichterstattung des Bundes (Hepatitis C. Health Report), Berli 2004 15
52. de Ridder M Dettmer K Hackenberg B Leicht A Hepatitisimpfung auf offenen Drogenszenen (Hepatitis-vaccination in open drug scenes) Deutsches Ärzteblatt 2004 101 A2893-A2896
53. Reimer J Lorenzen J Schäfer I Backmund M Bätz B Haasen C Virale Leberinfektionen bei intravenösen Drogengebrauchern (Viral infections of the liver in iv drug consumers) Suchtmed 2005 7 128
54. Gölz J Rockstroh J (ed) Compliance in der HIV-Therapie (Compliance in HIV-Therapy). Bremen/London/Boston 2001
55. Gölz J Moll A Nzimegne S Klausen G Schleehauf D Vergleich der antiretroviralen Behandlung bei Drogenabhängigen und homosexuellen Männern - retrospektive Auswertung von 1996 bis 2000 (Comparison of antiretroviral treatment of drug addicts and homosexual men) Suchtmed 2001 1 25-33
56. Gölz J Folgeerkrankungen des intravenösen Drogenkonsums. Hepatitiden (Hepatitis as a side effect of intravenous drug consumption). Moderne Suchtmedizin. Diagnostik und Therapie der somatischen, psychischen und sozialen Syndrome. (Modern Addiction Medicine: Diagnosis and Therapy of somatic, psychic and social syndroms). Stuttgart Gölz J 1999 C4.2.1-1-C4.2.1-15
57. Gölz J Klausen G Schleehauf D Therapie der chronischen Hepatitis C bei HIV/HCV-koinfizierten Drogenabhängigen (Therapy of Chronic Hepatitis C in HIV/HCV-Coinfected Drug Addicts) Suchttherapie 2006 7 2-7
58. Schäfer M Schmidt F Folwaczny C Lorenz R Martin G Schindlbeck N Heldwein W Soyka M Grunze H Koenig A Loeschke K Adherence and mental side effects during hepatitis C treatment with Interferon alfa and Ribavirin in psychiatric risk groups Hepatology 2003 37 443-451 10.1053/ jhep.2003.50031 12540795
59. Mauss S Berger F Goelz J Jacob B Schmutz G A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance Hepatology 2004 40 120-124 10.1002/hep.20279 15239094
60. Backmund M Reimer J Meyer K Gerlach T Zachoval R Hepatitis C Virus infection and injection drug users: Prevention, risk factors, and treatment Clinical Infection Diseases 2005 40 Suppl S 330-335 10.1086/ 427475
61. Backmund M Henkel C Scelsi M Meyer K Hepatitis C-Therapie während der Substitutionsbehandlung (Hepatitis C-Therapy during Maintenance Treatment) Suchtmed 2005 7 129
62. Schäfer M Berg T Die chronische Hepatitis C-Infektion: Häufigkeit, Verlauf und Stand der Behandlungsmöglichkeiten bei Patienten mit intravenöser Drogenabhängigkeit (Chronic Hepatitis C Infection: Frequency, development and state of the art of treatment in patients with intravenous drug addiction) Sucht 2005 51 97-108
63. Schäfer M Heinz A Backmund M Treatment of chronic hepatitis C in patients with addiction: Time to change the rules Addiction 2004 99 1167-1175 10.1111/j.1360-0443.2004.00821.x 15317637
64. Schäfer M Therapie der chronischen Hepatitis C bei Patienten mit psychischen Erkrankungen (Therapy of Chronic Hepatitis C in patients with psychiatric disorders) Suchttherapie 2005 6 66-69
65. Rockstroh J HIV and hepatitis C virus co-infection Lancet Infect Dis 2004 4 437-44 10.1016/S1473-3099(04)01059-X 15219554
66. Bühringer G Allocating treatment options to patients profils: clinical art or science? Addiction 2006 101, 5 646-652 10.1111/ j.1360-0443.2006.01366.x
67. European Monitoring Center for Drugs and Drug Addiction (EMCDDA) Annual Report 2006. The State of the drugs problem in Europe Lisbon 2006 30
68. United Nations Office on Drugs and Crime (UNODC) Word Drug Report 2006 Vienna 2006 74
69. Michels II Die Zukunft der Substitutionsbehandlung in China (The Future of substitution Treatment in China) Workshop of World Health Organisation (WHO) in Beijing on Substitution treatment of Opioid Dependents from 1 to 2 June 2006, in: Newsletter of the German Association of Addiction Medicine No. 8, July - August, Berlin/Hamburg 14